McAdam LLC’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$517K Buy
766
+148
+24% +$87.9K 0.02% 261
2026
Q2
$310K Buy
618
+34
+6% +$16.3K 0.01% 376
2026
Q1
$287K Buy
584
+123
+27% +$66.8K 0.01% 355
2025
Q4
$267K Buy
+461
New +$261K 0.01% 346
2025
Q1
– Sell
-448
Closed -$233K – 386
2024
Q4
$233K Buy
448
+16
+4% +$8.8K 0.01% 321
2024
Q3
$267K Buy
432
+15
+4% +$8.88K 0.02% 279
2024
Q2
$231K Buy
+417
New +$239K 0.01% 282
2024
Q1
– Sell
-395
Closed -$210K – 313
2023
Q4
$210K Buy
+395
New +$191K 0.02% 262
2018
Q2
– Sell
-16
Closed -$3K – 803
2018
Q1
$3K Buy
+16
New +$3.36K ﹤0.01% 489

Other funds holding TMO

McAdam LLC's TMO Position: Q3 2026 in Review

McAdam LLC increased its Thermo Fisher Scientific (TMO) stake by 24% in Q3 2026, buying an estimated $87.9K and bringing the position to 766 shares worth $517K. The position accounts for 0.02% of the portfolio, ranked #261.

McAdam LLC first reported a position in TMO in Q1 2018 and has held it in 9 quarters since. 1,033 funds tracked by Wall St. Rank hold TMO as of Q3 2026.

  • McAdam LLC held 766 shares of Thermo Fisher Scientific worth $517K as of Q3 2026.
  • McAdam LLC bought 148 Thermo Fisher Scientific shares in Q3 2026, an estimated $87.9K.
  • Thermo Fisher Scientific made up 0.02% of McAdam LLC's portfolio in Q3 2026, its #261 holding.
  • McAdam LLC first reported a position in Thermo Fisher Scientific in Q1 2018 and has held it in 9 quarters since.
  • 1,033 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.

Based on McAdam LLC's 13F filing for Q3 2026, filed 21 Oct 2026.